Histoplasmosis.
Histoplasmosis is the most prevalent endemic fungal infection in North America. The clinical spectrum ranges from asymptomatic, self-limited illness to a life-threatening progressive disseminated disease. Chronic manifestations of healed infection can also be problematic. Clinical presentation depends on the infectious load, underlying immune status, and lung function. The preferred diagnostic methods and treatment options vary with clinical scenario and severity of illness. New diagnostic tools and treatment options are now available in clinical practice. We present an overview of this important endemic mycosis with emphasis on diagnosis and treatment recommendations for the different clinical syndromes of histoplasmosis.
Knox
Kenneth S
KS
University of Arizona College of Medicine and Southern Arizona VA HealthCare System, Tucson, Arizona, USA. chage@iupui.edu
Hage
Chadi A
CA
D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001982:Bronchial Diseases / Q000382:microbiology; D018893:Bronchoalveolar Lavage; D018450:Disease Progression; D006660:Histoplasmosis / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host; D017964:Itraconazole / Q000008:administration & dosage / Q000627:therapeutic use; D020347:Lithiasis / Q000382:microbiology; D008172:Lung Diseases, Fungal / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy; D055613:Multiple Pulmonary Nodules / Q000382:microbiology; D003074:Solitary Pulmonary Nodule / Q000382:microbiology; D016896:Treatment Outcome
D000935:Antifungal Agents; D017964:Itraconazole